Skip to main content
Log in

Altered Chemokine Receptor Sensitivity in FVBN202 Rat neu Transgenic Mice

Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

We report here that breast cancer cells from spontaneous tumors that arise in rat neu transgenic mice produce several chemokines capable of acting upon cells of the immune system. Moreover, mice bearing these spontaneous tumors possess splenic T cells as well as CD11c+, CD11b+ and CD19+ cells with an altered sensitivity to recombinant chemokines compared to naïve mice. A comparison between T-cell migration and the level of chemokines produced by the tumor cells revealed that the altered chemotactic activity was not a direct consequence of tumor-derived chemokines. These data suggest that a growing tumor may indirectly alter leukocyte chemotactic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Peng L, Shu S, Krauss JC: Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells. Cancer Res 57: 4849-4854, 1997

    Google Scholar 

  2. Mrowietz U, Schwenk U, Maune S, Bartels J, Kupper M, Fichter I, Schroder JM, Schadendorf D: The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 79: 1025-1031, 1999

    Google Scholar 

  3. Youngs SJ, Ali SA, Taub DD, Rees RC: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71: 257-266, 1997

    Google Scholar 

  4. Kurt RA, Baher A, Wisner KP, Tackitt S, Urba WJ: Chemokine receptor desensitization in tumor-bearing mice. Cell Immunol 207: 81-88, 2001

    Google Scholar 

  5. Guy CT, Webster MA, Schaller M, Parsons TJ, Carl RD, Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Nat Acad Sci (Wash) 89: 10578-10582, 1992

    Google Scholar 

  6. Kurt RA, Whitaker R, Baher A, Seung S, Urba WJ: Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice. Int J Cancer 87: 688-694, 2000

    Google Scholar 

  7. Morris AJ, Malbon CC: Physiological regulation of G proteinlinked signaling. Phys Rev 79: 1373-1429, 1999

    Google Scholar 

  8. Saeki H, Moore AM, Brown MJ, Hwang ST: Secondary lymphoid tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162: 2472-2475, 1999

    Google Scholar 

  9. Campbell JJ, Junliang P, Butcher EC: Developmental switches in chemokine responses during T cell maturation. J Immunol 163: 2353-2357, 1999

    Google Scholar 

  10. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT: A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95: 258-263, 1998

    Google Scholar 

  11. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ: High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 155: 4838-4843, 1995

    Google Scholar 

  12. Lukacs NW, Kunkel SL, Strieter RM, Chensue SW: The role of chemokines in schistosoma mansoni granuloma formation. Parasit Today 10: 322-324, 1994

    Google Scholar 

  13. Dabbagh K, Xiao Y, Smith C, Stepick-Biek P, Kim SG, Lamm WJ, Liggitt DH, Lewis DB: Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI. J Immunol 165: 3418-3422, 2000

    Google Scholar 

  14. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ: CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617-7624, 2001

    Google Scholar 

  15. Neumark E, Anavi R, Witz IP, Ben-Baruch A: MCP-1 expression as a potent contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells. Immunol Lett 68: 141-146, 1999

    Google Scholar 

  16. Bacon KB, Premack BA, Gardner P, Schall TJ: Activation of dual signaling pathways by the chemokine RANTES. Science 269: 1727-1730, 1995

    Google Scholar 

  17. Appay V, Dunbar PR, Cerundolo V, McMichael A, Czaplewski L, Rowland-Jones S: RANTES activates antigenspecific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. Int Immunol 12: 1173-1182, 2000

    Google Scholar 

  18. Zou W, Machelon V, Coulomb-L'Herman A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, Curiel TJ: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7: 1339-1346, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurt, R.A., Bauck, M., Harma, S. et al. Altered Chemokine Receptor Sensitivity in FVBN202 Rat neu Transgenic Mice. Breast Cancer Res Treat 77, 225–232 (2003). https://doi.org/10.1023/A:1021853202515

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021853202515

Navigation